Cohort profile: Outcomes & Multi-morbidity In Type 2 diabetes (OMIT) - a national registry-based observational cohort with focus on care and treatment of key high-risk groups in Norway.
Rachel B ForsterRagnhild B StrandbergKatrina Louise Bø TibballsKjersti NøklebyTore Julsrud BergTor IversenTerje P HagenKåre Rønn RichardsenJohn CooperSverre SandbergKarianne Fjeld LøvaasRoy Miodini NilsenMarjolein Memelink IversenAnne Karen JenumEsben Selmer Selmer BuhlPublished in: BMJ open (2022)
The OMIT cohort features 5784 subjects with T2D in 2006, a number that has grown to 57 527 in 2019 and is expected to grow further via repeated linkages performed every third to fifth year. At the next wave of data collection, additional linkages to Norwegian Patient Registry and Norwegian Cause of Death Registry for data on registered diagnoses and causes of death, respectively, will be performed.